[Do not overuse doxycycline as prophylaxis for uncomplicated sexually transmitted infections]

Lakartidningen. 2024 Aug 2:121:24036.
[Article in Swedish]

Abstract

STI prophylaxis using doxycycline is discussed internationally for persons at high risk of STIs (Doxy-PEP). Doxy-PEP would probably have limited effect on gonorrhoea due to resistance to tetracyclines. Doxy-PEP may reduce the incidence of chlamydia and syphilis, but would not reduce the number of complicated infections. Further studies are needed on the effects of intermittent antibiotic use on the microbiome or antibiotic resistance in general.

Publication types

  • English Abstract

MeSH terms

  • Anti-Bacterial Agents* / administration & dosage
  • Anti-Bacterial Agents* / adverse effects
  • Anti-Bacterial Agents* / therapeutic use
  • Antibiotic Prophylaxis
  • Chlamydia Infections* / drug therapy
  • Chlamydia Infections* / prevention & control
  • Doxycycline* / administration & dosage
  • Doxycycline* / therapeutic use
  • Drug Resistance, Bacterial
  • Gonorrhea* / drug therapy
  • Gonorrhea* / prevention & control
  • Humans
  • Sexually Transmitted Diseases* / prevention & control
  • Syphilis / drug therapy
  • Syphilis / prevention & control

Substances

  • Doxycycline
  • Anti-Bacterial Agents